Status:
RECRUITING
Prospective Cohort Study on Antibiotic Course and Efficacy After Two-stage Revision in PJI.
Lead Sponsor:
First Affiliated Hospital of Fujian Medical University
Conditions:
Periprosthetic Joint Infection
Anti-Bacterial Agents
Eligibility:
All Genders
18+ years
Brief Summary
This is a multicenter prospective cohort study in which patients were evaluated by inclusion and exclusion criteria before phase II revision surgery. Eligible patients will be included in this study a...
Detailed Description
Inclusion criteria： 1. A diagnosis of PJI was made according to MSIS criteria 2. Received spacer implantation and a full course of antibiotic treatment (at least 6 weeks), the patient was clinically ...
Eligibility Criteria
Inclusion
- \- 1. A diagnosis of PJI was made according to MSIS criteria. 2. Received spacer implantation and a full course of antibiotic treatment (at least 6 weeks), the patient was clinically determined to have infection control and underwent secondary joint revision.
- 3\. Age ≥18 years old. 4. The patient voluntarily participated in the study, and was physically and mentally tolerant to the treatment process and various tests of the study. He has signed an informed consent form and passed the examination of all the hospital ethics committees participating in the study.
Exclusion
- 1\. Follow-up data not available. 2. Researchers judge that patients no longer meet the standards of the study due to compliance problems
Key Trial Info
Start Date :
December 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05284318
Start Date
December 1 2021
End Date
December 31 2026
Last Update
March 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China